Related Experiment Video

Updated: Aug 8, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor

Hans R Widlund1, Martin A Horstmann, E Roydon Price

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Dana 630, 44 Binney Street, Boston, MA 02115, USA.

The Journal of Cell Biology
|September 18, 2002
PubMed

Insights

Beta-catenin signaling promotes melanoma growth and survival by regulating Microphthalmia-associated transcription factor (MITF). Constitutive MITF expression rescues melanoma cells when beta-catenin signaling is blocked, highlighting a key pathway in this cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Microphthalmia-associated transcription factor (MITF) is crucial for melanocyte differentiation and pigmentation.
  • MITF acts downstream of the Wnt pathway in melanocyte development.
  • MITF remains expressed in human melanoma, even in unpigmented tumors, suggesting roles beyond differentiation.

Purpose of the Study:

  • To investigate the role of beta-catenin in melanoma growth and survival.
  • To determine if beta-catenin influences melanoma via its downstream target MITF.

Main Methods:

  • Examined beta-catenin deregulation (nuclear accumulation) in human melanomas.
  • Assessed the impact of beta-catenin on melanoma cell growth and survival.
  • Investigated the rescue effect of constitutive MITF on melanoma growth inhibition caused by beta-catenin pathway disruption.

Main Results:

  • Beta-catenin significantly mediates melanoma cell growth in a manner dependent on MITF.
  • Suppression of melanoma clonogenic growth by disrupting beta-catenin-TCF/LEF interactions was rescued by constitutive MITF expression.
  • This rescue mechanism is largely prosurvival.

Conclusions:

  • Beta-catenin regulates MITF expression in melanoma cells.
  • This beta-catenin-MITF pathway is critical for the growth and survival of melanoma.
  • Targeting this pathway may offer therapeutic strategies for treatment-resistant melanoma.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...